Prices of 869 formulations to go up by 3.44 percent: NPPA Ruby Khatun Khatun3 April 2018 10:00 AM ISTNew Delhi: Prices of 869 formulations, including antibiotics, cancer and cardiovascular disease treatment drugs and two types of coronary stents, have...
FDA refuses to review Alkermes depression treatment, seeks more trials Ruby Khatun Khatun3 April 2018 9:45 AM ISTAlkermes Plc has been told to conduct more clinical trials of its experimental depression treatment after the U.S. Food and Drug Administration...
Celgene Chief Operating Officer Scott Smith abruptly resigns Ruby Khatun Khatun3 April 2018 9:30 AM ISTCelgene Corp said Chief Operating Officer Scott Smith is leaving the company, effective immediately.The company did not cite a reason for his...
Streamline Ayush systems of medicine: Parliamentary Panel Ruby Khatun Khatun2 April 2018 11:24 AM ISTNew Delhi: The need of the hour to streamline the Ayush systems of medicines by standardization and quality control of Ayurveda, Siddha, Unani and...
Policybazaar.com to foray into healthcare and tech services Ruby Khatun Khatun2 April 2018 10:00 AM ISTNew Delhi: Policybazaar.com, India's largest insurance website and comparison portal is planning to foray into the healthcare technology and services...
Drug companies want Supreme Court to take eye drop dispute Ruby Khatun Khatun2 April 2018 9:45 AM ISTWASHINGTON: The Supreme Court is being asked to take a case about whether eye drops are too big.Don't roll your eyes. Major players in American's...
Shire soars as Japan's Takeda considers bid Ruby Khatun Khatun2 April 2018 9:30 AM ISTLONDON/TOKYO: Japan's largest drugmaker Takeda Pharmaceutical is considering a bid for London-listed rare disease specialist Shire that could top $40...
Lupin launches generic psoriasis drug in US Ruby Khatun Khatun1 April 2018 10:30 AM ISTNew Delhi: Drug firm Lupin said it has launched its Clobetasol Propionate spray, used for treating plaque psoriasis, in the American market.The...
Mylan gets FDA approval for HIV treatment Ruby Khatun Khatun1 April 2018 10:15 AM ISTGlobal pharmaceutical company Mylan N.V. announced that it will introduce in the U.S. a third cost-saving HIV combination.The U.S. Food and Drug...
HealthCare Global Enterprises transfers entire stake holding in HCG Regency Oncology Healthcare Ruby Khatun Khatun1 April 2018 9:45 AM ISTNew Delhi: HealthCare Global Enterprises Limited has informed the BSE that the company has entered into a Share Purchase Agreement with Regency...
FDA expands use of Amgen leukemia drug Blincyto to patients with relapse risk Ruby Khatun Khatun1 April 2018 9:30 AM ISTThe U.S. Food and Drug Administration (FDA) expanded the use of Amgen Inc’s leukemia drug Blincyto to include patients who are in remission but still...
Lupin gets USFDA approval for generic psoriasis drug Ruby Khatun Khatun31 March 2018 10:30 AM ISTNew Delhi: Drug major Lupin said it has received USFDA's approval to market Clobetasol Propionate spray, used for treating plaque psoriasis, in the...
